Superior efficacy of combination therapy for rheumatoid arthritis: Fact or fiction?
- 30 September 2005
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (10), 2975-2983
- https://doi.org/10.1002/art.21293
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Sulfasalazine is a potent inhibitor of the reduced folate carrier: Implications for combination therapies with methotrexate in rheumatoid arthritisArthritis & Rheumatism, 2004
- Rheumatoid arthritis in 2003: where are we now with treatment?Annals Of The Rheumatic Diseases, 2003
- Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational studyAnnals Of The Rheumatic Diseases, 2003
- The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD coursesRheumatology, 2002
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Expectation bias in rheumatoid arthritis clinical trials. The anti‐CD4 monoclonal antibody experienceArthritis & Rheumatism, 1996
- The efficacy and toxicity of combination therapy in rheumatoid arthritis. a meta‐analysisArthritis & Rheumatism, 1994
- The use of combinations of disease‐modifying antirheumatic agents in rheumatoid arthritisArthritis & Rheumatism, 1990
- COMBINATION CHEMOTHERAPY IN RHEUMATOID ARTHRITISRheumatology, 1987
- Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquineJAMA, 1982